金币
UID176556
帖子
主题
积分25076
注册时间2014-6-6
最后登录1970-1-1
听众
性别保密
|
发表于 2017-9-21 18:12:59
|
显示全部楼层
一般的临床一期如果在合乎条件的实验室做,则由研发人员制定,如果是在车间,还是车间制定好!
E. Manufacturing and Records
The manufacture of phase 1 investigational drugs should follow written manufacturing and
process control procedures that provide for the following records.
A record of manufacturing data that details the materials, equipment, procedures used,
and any problems encountered during manufacturing. We recommend that
manufacturers retain records sufficient to replicate the manufacturing process. Similarly,
if the manufacture of a phase 1 investigational drug batch is initiated but not completed,
we recommend that the record include an explanation of why manufacturing was
terminated.
A record of changes in procedures and processes used for subsequent batches along with
the rationale for any changes
A record of the microbiological controls that have been implemented (including written
procedures) for the production of sterile-pro cessed phase 1 investigational drugs that are
covered by this guidance. You should follo w the recommendations for use of aseptic
techniques and the control of in-process materials, components, and container closures
designed to prevent microbial and endotoxin contamination (see section VI.C).
9
|
|